Literature DB >> 20473764

Are estrogen receptors alpha detectable in normal and abnormal thyroid tissue?

Michael Vaiman1, Youlian Olevson, Judith Sandbank, Liliana Habler, Sergei Zehavi, Alex Kessler.   

Abstract

The aims of this study is to evaluate the presence of estrogen receptors alpha (ERα) in thyroid lesions and to assess the practicality of this test in view of numerous disagreements on the subject. Immunohistochemical stains were performed for ERα, for the evaluation of immunoreactivity in 296 pathological thyroid tissue samples. We evaluated the intensity of the nuclear and cytoplasmatic staining and the spread of the stain over the sample. Thirty cases of the breast cancer served as a control group. None of the histological thyroid samples showed immunoreactivity for ERα. No difference was found between the various lesions in regard to this absence. The ERα rate of expression in the breast cancer samples was 60%. The ERα is undetectable in the histological samples of benign and malignant thyroid lesions. Further investigation is necessary in the laboratory immunohistochemical workup in order to exclude a possibility of non-specific staining.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473764     DOI: 10.1007/s00405-010-1269-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  29 in total

1.  ER beta: identification and characterization of a novel human estrogen receptor.

Authors:  S Mosselman; J Polman; R Dijkema
Journal:  FEBS Lett       Date:  1996-08-19       Impact factor: 4.124

2.  Estrogen receptor (ER)-beta, but not ER-alpha, is present in thyroid vessels: immunohistochemical evaluations in multinodular goiter and papillary thyroid carcinoma.

Authors:  Graziano Ceresini; Simonetta Morganti; Virna Graiani; Maria Saccani; Bruna Milli; Elisa Usberti; Giorgio Valenti; Gian Paolo Ceda; Luigi Corcione
Journal:  Thyroid       Date:  2006-12       Impact factor: 6.568

3.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

4.  Immunoperoxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval.

Authors:  A K Katoh; N Stemmler; S Specht; F D'Amico
Journal:  Biotech Histochem       Date:  1997-11       Impact factor: 1.718

5.  Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma.

Authors:  N M Diaz; G Mazoujian; M R Wick
Journal:  Arch Pathol Lab Med       Date:  1991-12       Impact factor: 5.534

6.  Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue.

Authors:  Y Hiasa; H Nishioka; Y Kitahori; K Yane; S Nakaoka; M Ohshima; N Konishi; K Nishii; M Kitamura; T Matsunaga
Journal:  Oncology       Date:  1993 Mar-Apr       Impact factor: 2.935

7.  Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.

Authors:  Wakako Kawabata; Takashi Suzuki; Takuya Moriya; Keisei Fujimori; Hiroshi Naganuma; Satoshi Inoue; Yositaka Kinouchi; Kaori Kameyama; Hiroshi Takami; Tooru Shimosegawa; Hironobu Sasano
Journal:  Mod Pathol       Date:  2003-05       Impact factor: 7.842

8.  Immunoperoxidase localization of estrogen receptors in human brest carcinoma.

Authors:  J C Garancis; L S Miller; J T Tomita; T M Tieu; L J Clowry
Journal:  Cancer Detect Prev       Date:  1983

9.  Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.

Authors:  N A Samaan; Y K Maheshwari; S Nader; C S Hill; P N Schultz; T P Haynie; R C Hickey; R L Clark; H Goepfert; M L Ibanez; C E Litton
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

10.  Expression of the estrogen receptor in human thyroid neoplasms.

Authors:  K Yane; Y Kitahori; N Konishi; K Okaichi; T Ohnishi; H Miyahara; T Matsunaga; J C Lin; Y Hiasa
Journal:  Cancer Lett       Date:  1994-08-29       Impact factor: 8.679

View more
  2 in total

Review 1.  Estrogens and stem cells in thyroid cancer.

Authors:  Mariangela Zane; Veronica Catalano; Emanuela Scavo; Marco Bonanno; Maria Rosa Pelizzo; Matilde Todaro; Giorgio Stassi
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-25       Impact factor: 5.555

2.  Expression of estrogen and progesterone receptors in papillary thyroid carcinoma.

Authors:  Mohammad-Reza Jalali-Nadoushan; Reza Amirtouri; Ali Davati; Samaneh Askari; Sepideh Siadati
Journal:  Caspian J Intern Med       Date:  2016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.